Scientists From the Terasaki Institute for Biomedical Innovation Ranked Among Most Highly Cited Researchers for 2021

December 3, 2021

(LOS ANGELES) – A recent announcement of their 2021 highly cited researchers was made by Clarivate Analytics. The rankings are based on research papers published from January 2010 to December 2020, with each author assigned to one of 22 fields in science and social science. Each scientist on the list is ranked in the top 1% for highly cited papers in their field.

Two scientists on the list are from the Terasaki Institute for Biomedical Innovation (TIBI); Dr. Ali Khademhosseini was named under the three categories of Biology and Biochemistry, Materials Science, and Pharmacology and Toxicology, and Dr. Mehmet R. Dokmeci was named under the Cross-Field category. Follow the links to bios and lists of their 2020 publications.

Dr. Ali Khademhosseini, CEO and Founding Director
Dr. Mehmet R. Dokmeci, Associate Professor
Terasaki Institute Welcomes Academic Entrepreneur, Dr. Xiling Shen, as new Chief Scientific Officer

November 18, 2021

(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) announces the hiring of its Chief Scientific Officer, Professor Xiling Shen. Professor Shen is a highly-accomplished scientist whose works span the multidisciplinary fields of biomedical engineering, computational techniques, cancer biology, and multi-omics methodologies.

Terasaki Institute for Biomedical Innovation’s Chief Innovation Officer Awarded Knighthood

October 25, 2021

Terasaki Institute for Biomedical Innovation’s Chief Innovation Officer Awarded Knighthood

(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation’s Chief Innovation Officer, Maurizio Vecchione, has recently been awarded the Order of Merit of the Italian Republic. The highest-ranking honor of the Republic, it is awarded for meritorious service or achievement in the fields of public service, economy, literature and the arts, as well as for social, philanthropic and humanitarian activities.

Preventing Postsurgical Adhesions using Hydrogel Barriers

October 20,2021

Preventing Postsurgical Adhesions using Hydrogel Barriers

(LOS ANGELES)–Following surgery within the abdominal or pelvic cavities, scar tissue often forms on the inner linings of these cavities and may adhere to the organs which are found within them. This adhesion occurs in 93% of these patients and can affect the intestines, liver, urinary bladder, gall bladder and female reproductive organs. In up to 20% of adhesion cases, serious complications can arise, including chronic abdominal or pelvic pain, fertility problems or intestinal obstruction. This not only results in increased patient suffering and mortality but adds over $1 billion in additional hospital costs in the United States alone.

Terasaki Institute for Biomedical Innovation Signs Agreement with Qatar Foundation

October 15,2021

Terasaki Institute for Biomedical Innovation Signs Agreement with Qatar Foundation

(LOS ANGELES)–The Terasaki Institute for Biomedical Innovation (TIBI) has recently signed an agreement with Qatar Foundation. Qatar Foundation is comprised of over 50 entities and is a non-profit organization that supports work in education, research, and community development. Under the umbrella of Qatar Foundation’s Research, Development, and Innovation division (QF RDI), the Qatar Genome Programme integrates genomic and omics data with phenotypic data from Qatar Biobank to facilitate precision medicine and effective health care for the Qatari population.

Improving Strength, Stretchiness and Adhesion in Hydrogels for Wound Healing

August 30,2021

Scientists use the adhesive capabilities of mussels as a model for optimizing hydrogels’ mechanical properties

(LOS ANGELES)–Hydrogels are everywhere. They are water-loving polymers which can absorb and retain water and can be found in such everyday consumer products such as soft contact lenses, disposable diapers, certain foods, and even in agricultural applications. They are also extremely useful in several medical applications due to their high degree of biocompatibility and their ability to eventually degrade and be reabsorbed into the body.

Terasaki Institute's Unique Approach to Innovation

August 23,2021

Written by Chief Innovation Officer, Maurizio Vecchione

(LOS ANGELES)– I have often been asked what makes the Terasaki Institute for Biomedical Innovation (TIBI) a unique place for both biomedical research and innovation. Of course, there is the caliber of our faculty, with their world-renowned platforms in leading biomedical frontiers, which include biomaterials, tissue engineering and organs on a chip, and the caliber of our research facilities which provides a unique, state-of-the-art inter-disciplinary laboratory that is home to our science work. But the most important feature might just be our commitment to innovation and the unique process of innovation that we are developing.

Next Generation Electronics: Expanding the Possibilities with Silver Nanowires

August 16,2021

Scientists improve the longevity of silver nanowires to enhance capabilities in electronic devices

(LOS ANGELES)–Today’s nanoscale technologies are sophisticated enough to be applied in an endless number of useful devices, from sensors in touch screen devices and household appliances to wearable biosensors that can monitor chemical levels in our blood, muscle movement, breathing and pulse rate. In addition, there are technologies for precision devices such as high-resolution scanning probe microscopes which enable one to visualize surfaces not only at the atomic level, but even the individual atoms themselves.

Our Locations

Follow Us